Victor Pharmacy Ltd. engages in the identification, development, and commercialization of approved drugs and drug candidates for new indications. It has two phase III clinical development programs underway to evaluate CellCept, an orally delivered immunosuppressant agent, in the treatment of the autoimmune diseases, such as lupus nephritis and pemphigus vulgaris. The company operates in Canada, United States, Switzerland, and the United Kingdom.more...
The Yellow Pages Guidelines describes the type of content which is not appropriate on the site. We may remove content that we consider to be offensive or otherwise in breach of these guidelines. Please help us respond more quickly by choosing how this content may be inappropriate.
Thanks for your help
The review has been reported to our moderators and will undergo a review process.